Business Context and Reporting Period
This Form 8-K is a current report filed by Aldeyra Therapeutics, Inc. on September 5, 2014. The filing serves as a Regulation FD disclosure to announce the Company's scheduled participation in two upcoming investment conferences: the 16th Annual Rodman & Renshaw Global Investment Conference (September 8–10, 2014) and the Aegis Capital Corporation 2014 Healthcare and Technology Conference (September 10–13, 2014).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. As a pre-revenue biotechnology company in an early stage of development, Aldeyra Therapeutics, Inc. does not currently generate significant revenue. The document references the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2014, for detailed financial data.
Material Changes
No material changes to financial results or operations are reported in this filing. The document solely discloses the Company's intent to present information to investors at the specified conferences.
Guidance, Outlook, and Risks
The filing contains extensive forward-looking statements regarding the Company's future expectations. Key risks and contingencies highlighted include:
- The timing and success of preclinical studies and clinical trials.
- The ability to obtain and maintain regulatory approval for product candidates.
- The scope, progress, and costs of developing and commercializing products.
- The sufficiency of current cash resources and the potential need for additional financing.
- The ability to attract or retain key personnel.
Management explicitly states that actual results may differ materially from forward-looking statements and declines any obligation to update these statements in the future.
Key Facts for Investor Verification
- Verify the specific dates and locations of the Rodman & Renshaw and Aegis Capital conferences.
- Review the attached presentation slides (Exhibit 99.1) and press release (Exhibit 99.2) for detailed strategic updates.
- Consult the Form 10-Q filed on August 7, 2014, for the most recent audited financial position and cash runway.
- Assess the "Risk Factors" section of the Company's final prospectus for a comprehensive list of potential operational and financial hurdles.